(Q46075759)

English

The effectiveness and safety of mycophenolate mofetil in lupus nephritis

scientific article published on 25 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

The effectiveness and safety of mycophenolate mofetil in lupus nephritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

author name string

Mazen Elyan

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

Stanley Ballou

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

publication date

25 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

28

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

835-840

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential therapies for proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes in African Americans and Hispanics with lupus nephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of ACR renal criteria in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19319623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-009-1163-6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19319623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46075759&oldid=2090708710"